Revised: 13 April 2017
This section provides information useful to healthcare professionals.
|13 April 2017||Committees||Medicines Adverse Reactions Committee - Minutes for the 169th meeting - 9 March 2017|
|27 March 2017||Committees||Opportunity to join the Medicines Adverse Reactions Committee|
|27 March 2017||Dear Healthcare Professional Letter||Zelboraf - Risk of Dupuytren's Contracture and Plantar Fascial Fibromatosis|
|24 March 2017||Monitoring Communicatoin||Animas Vibe Insulin Pump and Blood Glucose Analyser - ongoing issues with screen fade, cracked battery casing and other issues.|
|24 March 2017||Alert Communiation||Andrographis paniculata – potential risk for allergic reactions|
|13 March 2017||Monitoring Communication||Viekira Pak and Viekira Pak-RBV – Possible effects on blood glucose control when used in patients with type 2 diabetes|
|8 March 2017||Committees||Addition to Agenda for the 58th meeting of the Medicines Classification Committee - 16 May 2017|
|2 March 2017||Monitoring Communication||Possible risk of hypothyroidism in infants exposed to iodine-containing contrast agents added to the medicines monitoring scheme|
|2 March 2017||Educational Material||Hydroxychloroquine - what you can expect when starting treatment (PDF 264 KB, 2 pages)|
How medicines are classified, guidance for natural health practitioners and data sheets.
Safety related information on medicines and medical devices including recalls, early warnings and adverse reactions.
Healthcare professionals responsibilities with regard to the use of medicines and medical devices on patients.
How to report quality and safety concerns with medicines and medical devices.
If you have an enquiry that is not answered by the information on the web site please contact us at email@example.com.